IX
ORIX Corp
$39.76
▲ 1.8%Updated Today 12:11 PM ET
IX at a glance — five pillars scored 0–100 from real filed financials.
Overall: Favorable · 61/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 73.6% over the last 12 months
Market Cap
$44.22B
P/E
14.76x
Forward P/E (est.)
11.48x
ROE
10.1%
Revenue Growth
15.9%
EPS Growth
28.5%
Profit Margin
13.4%
FCF Yield
—
Debt / Equity
1.46x
ROIC
2.0%
Interest Coverage
1.13x
Current Ratio
—
Dividend Yield
2.9%
Implied Growth (rev. DCF)
—
Rating Score
61/100
ORIX Corp (IX) is a large-cap company in the Financial Services industry, part of the Financials sector of the S&P 500, with a market value around $44.22B.
In its latest reported year it generated about $1.50T in revenue.
Our model rates IX Favorable (61/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what IX's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. IX trades near $39.76, above its 50-day average ($37.15) and 200-day average ($31.10). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 58 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. IX's is $0.81 (~2.0% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month IX found buyers near $37.73 (support) and sellers near $40.63 (resistance); its 52-week range is $22.10–$40.63. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.3× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
4.8%
Revenue moved from $2.68T in 2017 to $1.50T in 2026, a -6.2% compound annual growth rate. The most recent year grew a strong 15.9% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
44.2%
Operating Margin
13.7%
Net Margin
13.4%
ROE
10.1%
ORIX Corp keeps about 13.4% of each sales dollar as net profit, with a 44.2% gross margin and 13.7% operating margin. Return on equity is 10.1% and return on invested capital about 2.0%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$51.92B
Net Debt
$42.35B
Net Debt / EBITDA
—
Debt / Equity
1.46x
Leverage: debt-to-equity is 1.5x, and operating profit covers interest about 1.1x. That is a moderate, manageable debt load for most businesses. It carries roughly $51.92B of total debt against $9.57B of cash.
Operating CF
—
Free Cash Flow
—
FCF Margin
—
P/E
14.76x
P/S
1.98x
P/B
1.15x
EV / EBITDA
24.25x
IX trades at 14.8x trailing earnings (about 11.5x on estimated forward earnings), 2.0x sales, and 1.1x book value. That is an undemanding multiple — potentially cheap if the business is stable.
Where IX sits versus its Financials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 95 Financials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How IX stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.
In the Financials sector (181 S&P 500 companies), IX ranks #55 of 181 by our overall rating. It trades at roughly in line versus the sector on earnings (14.8x P/E vs. 15.3x median) with a lower return on equity (10.1% vs. 13.6%) and faster revenue growth (15.9% vs. 15.5%).
P/E vs sector
14.8x
median 15.3x
ROE vs sector
10.1%
median 13.6%
Growth vs sector
15.9%
median 15.5%
Sector rank
#55
of 181 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Financials companies by sub-industry and size. Sector median is across all 181 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $39.76 today · expected CAGR 142% – 168%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $1.74T | $2.02T | $2.35T | $2.72T | $3.16T |
| Net income | $226.81B | $263.10B | $305.19B | $354.02B | $410.67B |
| EPS | $201.77 | $234.05 | $271.50 | $314.94 | $365.33 |
| Share price (low) | $1,815.90 | $2,106.45 | $2,443.48 | $2,834.44 | $3,287.94 |
| Share price (high) | $3,026.50 | $3,510.75 | $4,072.46 | $4,724.06 | $5,479.91 |
| CAGR (low–high) | 4467% / 7512% | 628% / 840% | 295% / 368% | 191% / 230% | 142% / 168% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for IX:
- Revenue is growing 15.9% a year, a sign of real demand.
- Pays a 2.9% dividend on top of any price gains.
- Our model's overall read is Favorable (61/100).
The case against IX:
- Interest coverage is thin (1.1x), so debt costs bite.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Balance-sheet risk — debt/equity of 1.5x magnifies the impact of higher rates or weaker earnings.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen favourably: ORIX Corp is a large-cap financials business still growing nicely, with solid profitability, and a heavier debt load to watch. It trades at 14.8x earnings, which our model scores Favorable (61/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
IX — frequently asked questions
Is IX a good stock to buy?
We don't give buy or sell advice. Our model rates ORIX Corp Favorable (61/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is IX's rating on The Stocks School?
ORIX Corp currently scores 61/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does IX's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from ORIX Corp's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for IX calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this IX analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell IX. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.